![Mike Quirk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Mike Quirk worked as Director at AstraZeneca Pharmaceuticals LP from 2012 to 2014.
Dr. Quirk worked as Chief Scientific Officer at SAGE Therapeutics, Inc. from 2023 to 2025.
Dr. Quirk completed undergraduate and doctorate degrees at the Massachusetts Institute of Technology.
Ehemalige bekannte Positionen von Mike Quirk
| Unternehmen | Position | Ende |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2025 |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Direktor/Vorstandsmitglied | 01.05.2014 |
Ausbildung von Mike Quirk
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
24
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Health Technology |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
